SCHEMBL9540583

SCHEMBL9540583

CC(=O)c1ccc(O)c(OCc2ccccc2)c1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 3/20 0.60
SMN1; SMN2 Q16637 3/20 0.53
HPGD P15428 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
MRGPRX4 Q96LA9 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
SMPD1 P17405 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
BRD4 O60885 3/20 0.52
LMNA P02545 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HTT P42858 1/20 0.51
EGFR P00533 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1545310 0.88 EGFR (0.64) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL29803481 0.88 EGFR (0.64) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL3960943 0.88 NR4A2 (0.58) SMN1; SMN2HPGDNPC1RAB9AMRGPRX4
SCHEMBL3123036 0.88 MAOB (0.64) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL21588079 0.85 HPGD (0.68) SMN1; SMN2HPGDNPC1RAB9AL3MBTL1
SCHEMBL22015271 0.84 LMNA (0.62) SMN1; SMN2HPGDNPC1RAB9AMAPT
SCHEMBL31025721 0.84 NPC1 (0.75) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL22325324 0.84 MAOB (0.59) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL9236564 0.84 SMPD1 (0.73) MAOBSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL340620 0.84 NPC1 (0.75) MAOBSMN1; SMN2HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232251-A 3, 4-Dihydroxyacetophenone derivative, preparation method, application and pharmaceutical composition 潍坊医学院 2019-01-18 CN claimed
CN-109232251-B Caryopyrone derivatives, preparation method, application and pharmaceutical composition thereof 潍坊医学院 2022-03-25 CN disclosed
CN-109232251-B Caryopyrone derivatives, preparation method, application and pharmaceutical composition thereof 潍坊医学院 2022-03-25 CN disclosed
CN-109232251-A 3, 4-Dihydroxyacetophenone derivative, preparation method, application and pharmaceutical composition 潍坊医学院 2019-01-18 CN disclosed
WO-1993014751-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING AS ACTIVE PRINCIPLE ASSOCIATIONS OF VANADIUM AND/OR NIOBIUM WITH PYROCATECHOL DERIVATIVES I.R.2.M. (FR) 1993-08-05 WO disclosed
EP-0167204-B1 METHOD FOR IMPROVING THE ABSORPTION AND EFFECTIVENESS OF A CATECHOLAMINE COMPOUND SIMES S.p.A. Società Italiana Medicinali e Sintetici (IT) 1989-09-27 EP disclosed
US-4673671-A CONVERSION TO MONO O-PHOSPHATE ESTER SIMES SOCIETA ITALIANA MEDICINALI E SINTETICI S.P.A. (IT) 1987-06-16 US disclosed
EP-0167204-A1 Method for improving the absorption and effectiveness of a catecholamine compound SIMES S.p.A. Società Italiana Medicinali e Sintetici (IT) 1986-01-08 EP disclosed